Resources

Biotech: The Featherweight Champion Of The Markets

Biotech punches way above its weight-class, and that’s never been more apparent than in this pandemic and the race for a COVID vaccine. Read more. The post Biotech: The Featherweight Champion Of The Markets appeared first on Atlas Venture.

read more

Atlas Venture Welcomes Rajesh Devraj, PhD, as Venture Partner

Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced today that Rajesh (Raj) Devraj, PhD, is joining the firm as a venture partner. Devraj will be working with the Atlas team to identify and execute upon...

read more

Reuters: EU’s Lending Arm Approves 1 Trillion Euro Green Plan

LONDON (Reuters) – European Union governments approved a 1 trillion euro ($1.2 trillion) green “roadmap” for the bloc’s lending arm on Wednesday that will see it stop financing fossil fuel projects and airport expansions, though climate groups said it did not go far...

read more

PBS: America’s Medical Supply Crisis

Why was the United States left scrambling for critical medical equipment as the coronavirus swept the country? With the Associated Press and Global Reporting Centre, FRONTLINE investigates the fragmented global medical supply chain and its deadly consequences. View...

read more

Negotiating 101: Advice From The Trenches

In a recent blog post, I walked through my tips for reading your adversaries’ body language while maintaining your own poker face throughout negotiations. In this second post, I’ll share practical tactics for gaining leverage and using it wisely. Women of biotech,...

read more

Negotiating 101: Advice From The Trenches

It’s back-to-school season, and that puts me in the frame of mind to share some of the most important lessons I’ve learned in a long career focusing on one of the most daunting pillars of the biopharma BD world: the negotiation. By Deanna Petersen, Chief Business...

read more

Longwood, Atlas Venture inject $52M into cell therapy startup

The drug industry has funneled billions of dollars into cell therapies over the last several years. But there may be something new on the horizon, and a new Cambridge startup is angling to be at the forefront. Read more. The post Longwood, Atlas Venture inject $52M...

read more

Hiring In A Syndemic

I have many fond memories of St Patrick’s Day—most of them involve marching in the parade with a plastic bag and a few extra layers under my girl scout uniform. When you grow up in Ireland, cold rain is not grounds to cancel anything. By Aoife Brennan, CEO of Synlogic...

read more

It’s Raining Biotech SPACs!

SPACs are all the rage today. With the IPO market booming and public investors seeking better returns, blank check companies called “Special Purpose Acquisition Companies” (SPACs) have been fueling up their tanks and chasing down their merger targets. New ones are...

read more

Unemployment still rising in US

9 October The US economy showed some signs of recovery in the third quarter of 2020 but unemployment claims continue to remain above pre-pandemic levels. Layoffs are expected to rise over the next few months hampering recovery. Ben Casselman, economics/business/data...

read more

Orthofix Medical launches new bone graft delivery system

Orthofix Medical has launched a new O-GENESIS Graft Delivery System together with AlloQuent Structural Allograft Q-Pack, a ready-to-use form of cervical and lumbar spacers for allograft procedures. The O-GENESIS Graft Delivery System is designed to provide allograft,...

read more

Eurozone to retain fiscal support until pandemic passes

8 October Francesco Saraceno, Italian economist, shared an article on European Central Bank (ECB) President Christine Lagarde’s plans to retain monetary support until the crisis created by the Covid-19 pandemic is over. She noted that the policies adopted in the euro...

read more